CRISPR helps find new genetic suspects behind ALS/FTD – Drug Target Review
Drug Target Review |
CRISPR helps find new genetic suspects behind ALS/FTD
Drug Target Review NIH-funded researchers at Stanford University used the gene editing tool CRISPR-Cas9 to rapidly identify genes in the human genome that might modify the severity of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) caused by … CRISPR Screen Pulls Down Fresh Targets for C9ORF72 ALS |
